Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy.
PLoS One. 2018 Jun 28;13(6):e0199299. doi: 10.1371/journal.pone.0199299. eCollection 2018.
Appropriate algorithms for the prediction of cardiovascular risk are strongly suggested in clinical practice, although still controversial. In type 2 diabetes mellitus (T2DM), the beneficial effect of phosphodiesterase (PDE)-5 inhibitors is demonstrated on endothelial function but not on the estimation of cardiovascular risk.
To study whether the chronic Vardenafil administration to men with T2DM influences variables correlated with the predicted long-term cardiovascular risk calculated by different validated algorithms.
Per-protocol analysis of a longitudinal, prospective, randomized, placebo-controlled, double-blind, investigator-started, clinical trial. 54 male patients affected by T2DM were assigned to study (26patients) and control-group (28patients), respectively. The study included a treatment phase (24weeks) (Vardenafil/placebo 10mg twice-daily) and a follow-up phase (24weeks). Three time points were considered: baseline(V0), end of treatment(V1) and end of the study(V2). Parameters evaluated: endothelial health-related parameters and cardiovascular risk, assessed by calculating the Framingham (coronary hart disease [CHD], myocardial infarction [MI], stroke and cardiovascular disease [CVD]), ASSIGN and CUORE equations.
Predicted cardiovascular risk at ten years resulted different using the three algorithms chosen, without differences between study and control groups and among visits. IL-6 was directly related to CHD, CVD and CUORE scores at V1 and with MI and STROKE at V2. Similarly, hs-CRP was directly related to CHD, MI, STROKE and CUORE only at V1 in the study group. Testosterone serum levels were inversely related to CHD and MI at V1 in study group.
The predicted cardiovascular risk is different depending on the algorithm chosen. Despite no predictive risk reduction after six months of treatment, a possible effect of Vardenafil could be hypothesized through its action on inflammation markers reduction and through restoration of normal testosterone levels.
尽管存在争议,但在临床实践中强烈建议使用适当的心血管风险预测算法。在 2 型糖尿病(T2DM)中,磷酸二酯酶(PDE)-5 抑制剂对内皮功能具有有益作用,但对心血管风险的估计没有作用。
研究慢性他达拉非给药是否会影响不同验证算法计算的预测长期心血管风险相关变量。
一项纵向、前瞻性、随机、安慰剂对照、双盲、研究者启动、临床试验的按方案分析。54 名患有 T2DM 的男性患者被分配到研究组(26 名患者)和对照组(28 名患者)。该研究包括治疗阶段(24 周)(他达拉非/安慰剂 10mg 每日两次)和随访阶段(24 周)。考虑了三个时间点:基线(V0)、治疗结束时(V1)和研究结束时(V2)。评估参数:内皮健康相关参数和心血管风险,通过计算弗雷明汉(冠心病[CHD]、心肌梗死[MI]、中风和心血管疾病[CVD])、ASSIGN 和 CUORE 方程进行评估。
使用三种选择的算法,十年后预测的心血管风险不同,研究组和对照组之间以及各次访问之间没有差异。IL-6 在 V1 时与 CHD、CVD 和 CUORE 评分直接相关,在 V2 时与 MI 和 STROKE 直接相关。同样,hs-CRP 在研究组中仅在 V1 时与 CHD、MI、STROKE 和 CUORE 直接相关。研究组中,血清睾酮水平在 V1 时与 CHD 和 MI 呈负相关。
所选算法不同,预测心血管风险也不同。尽管治疗六个月后没有预测风险降低,但可以假设他达拉非通过降低炎症标志物和恢复正常睾酮水平来发挥作用。